Chlorambucil

Chlorambucil is an alkylating agent used in combination with prednisolone for the treatment of idiopathic membranous nephropathy. Chlorambucil significantly inhibites migration of EEC in Boyden chamber and wound healing experiments. The alkylating agent chlorambucil dramatically impairs directed cellular migration, which is accompanied by perturbations of cell polarity and mitochondrial membrane potential.